Canada· CA-DIN-02231584
EPREX STERILE SOLUTION 2000IU/0.5ML
A erythropoietin product containing epoetin alfa, registered in Canada by JANSSEN INC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Erythropoietin is registered in 12 of 19 countries.
Countries holding a registration under ATC B03XA01 (erythropoietin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Erythropoietin · ATC B03XA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- EPOETIN ALFA
- Manufacturer
- JANSSEN INC
- Country
- Canada (CA)
- ATC code
- B03XA01
- ATC class
- Erythropoietin
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for erythropoietin.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythropoietin · interactions on record
18 records
- 5 severe
- 3 moderate
- 10 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erythropoietin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABSEAMEDMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumAbseamed 1000 IU/0.5 mlMedice Arzneimittel Pütter
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- NetherlandsAbseamed 10.000 IE/1 ml oplossing voor injectie in een voorgevulde spuitMedice Arzneimittel Pütter GmbH & Co. KG
- SwedenAbseamed 10 000 IE/ 1 ml Injektionsvätska, lösning i förfylld sprutaMedice Arzneimittel Pütter GmbH & Co. KG
- PolandAbseamedMedice Arzneimittel Puetter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Germany · Erypo Fs
- Spain · Eprex
- France · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bea73349-66d1-480f-92ca-54eb171852fc GET /v1/drugs/bea73349-66d1-480f-92ca-54eb171852fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02231584",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B03XA01",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "50950",
"strengths": [
"2000 UNIT"
],
"ahfs_class": null,
"substances": [
"EPOETIN ALFA"
],
"product_categorization": null
}See everything about erythropoietin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.